Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Resverlogix Corp.    RVX   CA76128M1086

SummaryChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector newsTweets

Resverlogix : IIROC Trading Halt - RVX

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/13/2017 | 03:32pm CEST

TORONTO, Oct. 13, 2017 /CNW/ - The following issues have been halted by IIROC:

Company: Resverlogix Corp.

TSX Symbol: RVX (all issues)

Reason: Pending News

Halt Time (ET): 9:16: AM ET

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions

© Canada Newswire, source Canada Newswire English

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RESVERLOGIX CORP.
10/17 RESVERLOGIX : Announces $87 million private placement with shenzhen hepalink
10/13 RESVERLOGIX : IIROC Trade Resumption - RVX
10/13 IIROC Trade Resumption - Resverlogix Corp.
10/13 RESVERLOGIX : IIROC Trade Resumption - Resverlogix Corp.
10/13 RESVERLOGIX : IIROC Trading Halt - RVX
10/13 Resverlogix Announces $87 Million Private Placement with Shenzhen Hepalink
10/13 IIROC Trade Halt - Resverlogix Corp.
10/13 RESVERLOGIX : IIROC Trade Halt - Resverlogix Corp.
10/03 Resverlogix Announces Annual and Special Meeting of Shareholders
09/14 RESVERLOGIX : Closes Extension of Maturity Date of Loan and Announces Private Pl..
More news
News from SeekingAlpha
10/18 Resverlogix (RVXCF) Presents At 2017 BIO Investor Forum - Slideshow
10/13 Resverlogix secures $87M private capital raise
07/16 WEEK IN REVIEW : BGI Genomics Completes $81-Million Chi-Next IPO
06/28 DSMB recommends Resverlogix's late-stage study of lead candidate apabetalone ..
06/20 Resverlogix (RVXCF) Presents At BIO International Conference 2017 - Slideshow
Chart RESVERLOGIX CORP.
Duration : Period :
Resverlogix Corp. Technical Analysis Chart | RVX | CA76128M1086 | 4-Traders
Managers
NameTitle
Donald J. McCaffrey Chairman, President, CEO & Secretary
Anthony Brad Cann Chief Financial Officer
Norman C. W. Wong Chief Scientific Officer
Jan O. Johansson Senior Vice President-Medical Affairs
Michael T. Sweeney Senior Vice President-Clinical Development
Sector and Competitors
1st jan.Capitalization (M$)
RESVERLOGIX CORP.-11.38%137
INCYTE CORPORATION14.83%24 254
QUINTILES IMS HOLDINGS INC32.72%21 711
CELLTRION, INC.--.--%20 802
LONZA GROUP59.82%19 730
ALNYLAM PHARMACEUTICALS, INC.213.97%10 783